HB Wealth Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$606K Buy
18,527
+1,907
+11% +$68.6K ﹤0.01% 1005
2026
Q1
$588K Buy
16,620
+636
+4% +$25.9K ﹤0.01% 899
2025
Q4
$649K Buy
+15,984
New +$695K ﹤0.01% 785

Other funds holding CNMD

HB Wealth Management's CNMD Position: Q2 2026 in Review

HB Wealth Management increased its CONMED (CNMD) stake by 11% in Q2 2026, buying an estimated $68.6K and bringing the position to 18,527 shares worth $606K. The position accounts for ﹤0.01% of the portfolio, ranked #1005.

HB Wealth Management first reported a position in CNMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $649K in Q4 2025. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • HB Wealth Management held 18,527 shares of CONMED worth $606K as of Q2 2026.
  • HB Wealth Management bought 1,907 CONMED shares in Q2 2026, an estimated $68.6K.
  • CONMED made up ﹤0.01% of HB Wealth Management's portfolio in Q2 2026, its #1005 holding.
  • HB Wealth Management first reported a position in CONMED in Q4 2025 and has held it in 3 quarters since.
  • HB Wealth Management's CONMED position peaked at $649K in Q4 2025.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.